Financial statements Ipharm 5

Balance sheet of Ipharm 5

Company age:
Age:
11 y. 27 d.
Share capital:
Share capital:
300 000 PLN
Profit and loss statement Balance Profitability

Balance sheet data of IPHARM 5

Year
2018
2019
2020
2021
2022
2023
Total assets 584 744,05 598 410,10 690 514,19 825 709,61 823 911,76 761 582,00
A. Fixed assets 39 670,62 1 678,10 9 829,58 8 402,42 7 384,76 6 486,80
B. Current assets 535 317,95 596 732,00 680 684,61 817 307,19 816 527,00 755 095,20
C. Share capital contributions (basic funds) - - - - - -
D. Own shares (stocks) - - - - - -
Total liabilities 584 744,05 598 410,10 690 514,19 825 709,61 823 911,76 761 582,00
A. Equity 49 426,11 273,75 50 183,98 98 997,76 104 328,68 52 471,44
B. Liabilities and provisions for liabilities 535 317,94 598 136,35 640 330,21 726 711,85 719 583,08 709 110,56
I. Long-term liabilities - - - - - -
II. Short-term liabilities - - - - - -
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.
  • Fixed Assets - Assets held for a longer period, typically longer than a year, such as real estate or machinery.
  • Current Assets - Assets intended to be used or sold within a year, such as inventory, receivables, and cash.
  • Equity - The net value of a company's assets, representing the difference between its assets and liabilities.
  • Long-Term Liabilities - Financial obligations to be repaid over a period longer than a year, such as loans or bonds.
  • Short-Term Liabilities - Financial obligations to be repaid within a year, such as payables to suppliers or short-term loans.
  • Reserve Capital - A portion of equity set aside for specific purposes, such as covering losses or business development.